The conundrum of using hyperoxia in COVID-19 treatment strategies: may intermittent therapeutic hyperoxia play a helpful role in the expression of the surface receptors ACE2 and Furin in lung tissue…

RT @AbramsMarcD: @2022FK May he get well soon. Be careful about oxygen poisoning. Ask the doctor about it. https://t.co/oApuRuC1BE

@2022FK May he get well soon. Be careful about oxygen poisoning. Ask the doctor about it. https://t.co/oApuRuC1BE

The conundrum of using hyperoxia in COVID-19 treatment strategies: may intermittent therapeutic hyperoxia play a helpful role in the expression of the surface receptors ACE2 and Furin in lung tissue https://t.co/zjwRHqAaiS

@bharath_265 @bmadhu As cited below, could supplemental O2 be proving detrimental? (not only from ROS but from disruption of HIF-1a production, which is known to down regulate ACE2 expression in lungs) https://t.co/8JquK0Z8oM https://t.co/3UpN8o4aLy htt

The conundrum of using hyperoxia in COVID-19 treatment strategies: may intermittent therapeutic hyperoxia play a helpful role in the expression of the surface receptors ACE2 and Furin in lung tissue via triggering of HIF-1α? https://t.co/bxVC9oVklT @Sprin

https://t.co/N9haxD5bxP *Recently, evidence has been found that the ACE2-receptor in lung tissue, in combination with Furin, is essential for the development of COVID-19 [1–3]* Interesting....